Abstract
A series of novel 9-substituted (2-(3H-imidazo[1,2-a]purin-3-yl)ethoxy)methylphosphonic and 4-substituted (2-(1H-imidazo[2,1-b]purin-1-yl)ethoxy)methylphosphonic acids as tricyclic etheno analogs of potent antivirals and cytostatics PMEG and PMEDAP was synthesized and evaluated for their biological activity. Most of the compounds showed modest activity against varicella-zoster virus (VZV) and human cytomegalovirus (HCMV) except for (2-(9-oxo-5,9-dihydro-3H-imidazo[1,2-a]purin-3-yl)ethoxy)methylphosphonic acid 8 which proved markedly active against VZV and HCMV. None of the compounds tested exhibited any significant cytostatic effect.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenine / analogs & derivatives*
-
Adenine / chemical synthesis
-
Adenine / pharmacology
-
Antiviral Agents / chemical synthesis*
-
Antiviral Agents / pharmacology
-
Cell Proliferation / drug effects
-
Cytomegalovirus / drug effects
-
Guanine / analogs & derivatives*
-
Guanine / chemical synthesis
-
Guanine / pharmacology
-
Herpesvirus 3, Human / drug effects
-
Humans
-
Organophosphorus Compounds / chemical synthesis
-
Organophosphorus Compounds / pharmacology*
-
Structure-Activity Relationship
Substances
-
Antiviral Agents
-
Organophosphorus Compounds
-
9-((2-phosphonylmethoxy)ethyl)guanine
-
9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine
-
Guanine
-
Adenine